| Date | Title | Description |
| 13.03.2026 | XtalPi Holdings Limited to Announce 2025 Annual Results on March 25, 2026 | CAMBRIDGE, Mass., March 13, 2026 /PRNewswire/ -- XtalPi Holdings Limited ("XtalPi", or the "Company") (HKEX: 2228), a leading global technology company in integrating artificial intelligence (AI) and robotics for drug an... |
| 03.03.2026 | Diversity will define the next era of biotech infrastructure | - |
| 02.03.2026 | ReviR Therapeutics Announces First Participant Dosed in Phase 1 Study and Secures CDE Clearance for Two Orphan Indications in China, Supporting Future U.S. Expansion Strategy | Milestone marks the first clinical program for Charcot-Marie-Tooth disease and Vanishing White Matter disease.
SAN FRANCISCO and SHANGHAI, March 2, 2026 /PRNewswire/ -- ReviR Therapeutics, a clinical-stage biotechnology company pioneering A... |
| 09.02.2026 | Leading Automation Capabilities of XtalPi Recognized by Global Chemical Giant - Successful Launch of Advanced Automated Workstation at BASF | SHANGHAI, Feb. 9, 2026 /PRNewswire/ -- Chemistry serves as the foundational pillar of material innovation and transformation. It supports and shapes almost every aspect of modern industries. Recently, XtalPi Inc. (2228.HK), a global leader ... |
| 29.01.2026 | XtalPi Convenes Global Experts to Shape the Future of Molecular Glue Drug Discovery: From Serendipity to Precision | Global thought leaders presented cutting-edge research at the 2026 International Symposium on Molecular Glue Drug Discovery.
XtalPi unveils the AI-driven XGlue™ platform to enable rapid, closed-loop molecular glue drug discovery.
Cross-sect... |
| 07.11.2025 | SY Holdings Invited to Attend 2025 Hong Kong FinTech Week, Leveraging AI to Boost the Development and Global Expansion of SMEs | HONG KONG, Nov. 7, 2025 /PRNewswire/ -- From November 3 to 4, 2025, "Hong Kong FinTech Week x StartmeupHK Festival 2025" (hereinafter referred to as "Hong Kong FinTech Week") was grandly held at the Hong Kong Convention ... |
| 05.11.2025 | XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development | SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in AI drug discovery, today announced a strategic platform-based collaboration with Eli Li... |
| 21.10.2025 | AI-driven drugmakers fuel wave of cross-border deals in China | This year, cross-border deals in China’s innovative drug sector have accelerated, with artificial intelligence-driven firms emerging as key players. Syneron, Helixon, and XtalPi illustrate the trend, together closing business development (B... |
| 09.09.2025 | XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals | SHENZHEN, China, Sept. 9, 2025 /PRNewswire/ -- XtalPi Inc. (Stock Code: 2228.HK) has announced that PEP08, a next-generation PRMT5 inhibitor candidate developed through its AI drug discovery collaboration with PharmaEngine, Inc. (TWO:4162),... |
| 01.09.2025 | China Recap | Growth and strain | China Recap is a weekly roundup tracking Chinese companies expanding abroad, covering market entries, funding rounds, product launches, and global partnerships.
China’s corporate globalization strategy is evolving fast. Industry giants are ... |
| 27.08.2025 | XtalPi Holdings Announces 2025 Interim Results | SHENZHEN, China, Aug. 27, 2025 /PRNewswire/ --
Key Highlights from the Financial Report:
Revenue surged 404% year over year to RMB 517 million in the first half of 2025.
Adjusted net profit reached RMB 141 million, marking the company's fir... |
| 20.08.2025 | XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies | CAMBRIDGE, Mass., Aug. 20, 2025 /PRNewswire/ -- XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop therapeutics for immunological and inf... |
| 18.08.2025 | XtalPi Holdings Limited to Announce 2025 Interim Results on August 27, 2025 | CAMBRIDGE, Mass., Aug. 18, 2025 /PRNewswire/ -- XtalPi Holdings Limited ("XtalPi", or the "Company") (HKEX: 2228), a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and... |
| 16.08.2025 | Nation's AI-backed drug market hits global stride | China's artificial intelligence-driven drug discovery is accelerating its role as a prominent player in global biotech. Experts and industry insiders said the sector is drawing unprecedented international attention, even though no AI-discov... |
| 07.08.2025 | XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration | Strategic partnership leverages AI and robotics for novel therapeutics across oncology, immunology, inflammation, neurology, and metabolic diseases.
CAMBRIDGE, Mass., Aug. 7, 2025 /PRNewswire/ -- XtalPi (2228.HK), a leading global technolog... |
| 01.07.2025 | The AI Revolution in Drug Discovery: A New Era of Innovation | The landscape of drug discovery is undergoing a seismic shift. Two companies, XtalPi and Chai Discovery, are at the forefront of this transformation. They are harnessing the power of artificial intelligence (AI) to redefine how we approach ... |
| 01.07.2025 | The Future of Vaccines and Drug Discovery: A New Era in Healthcare | In the ever-evolving landscape of healthcare, two recent developments stand out: Moderna's promising flu vaccine and the collaboration between XtalPi and Pfizer in drug discovery. Both stories reflect a shift towards innovation, driven by t... |
| 30.06.2025 | XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations | CAMBRIDGE, Mass., June 30, 2025 /PRNewswire/ -- XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, ann... |
| 23.06.2025 | XtalPi Announces Strategic Collaboration with Harvard Professor Gregory Verdine's DoveTree LLC to Advance Novel Therapeutics Using AI+Robotics Drug Discovery Platform | CAMBRIDGE, Mass. , June 23, 2025 /PRNewswire/ -- XtalPi, a global leader in AI- and robotics-powered drug and materials discovery, today announced it has signed a Letter of Intent (LOI) with DoveTree LLC, founded by Harvard University Profe... |
| 13.06.2025 | XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration | CAMBRIDGE, Mass. and LIVERPOOL, United Kingdom, June 13, 2025 /PRNewswire/ -- XtalPi, a leading life sciences and new materials R&D platform powered by quantum physics, AI and robotics, today announced its acquisition of Liverpool Chiro... |
| 09.04.2025 | Guangdong's drive for AI and robotics innovation | This photo taken on March 1, 2024 shows robotic workstations developed by XtalPi Inc in Shenzhen, South China's Guangdong province. [Photo/Xinhua]
Guangdong is stepping up efforts to support the growth of artificial intelligence and robotic... |
| 28.03.2025 | XtalPi and Kula Bio Forge Multi-Million USD Collaborative R&D Agreement to Advance AI-Driven Microbial Fertilizers in China and the Middle East | CAMBRIDGE, Mass., March 28, 2025 /PRNewswire/ -- XtalPi (2228.HK) today announced the official signing of a strategic R&D collaboration agreement with U.S.-based Kula Bio in Boston. This partnership initiates a joint research initiative... |
| 09.01.2025 | UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform | Computational advancements enable earlier and more widespread use of antibody-antigen structural insights across drug discovery process
These advancements have the potential to transform antibody discovery methods, broadening therapeutic ap... |
| 13.11.2024 | Deals in brief: Vingroup pledges additional funding toward EV arm, Intudo Ventures raises USD 125 million, latest China deals, and more | Vingroup pledges additional funding to keep VinFast rolling forward
Vingroup, one of Vietnam’s primary conglomerates, has pledged an additional VND 35 trillion (USD 1.4 billion) to support its electric vehicle arm, VinFast, through 2026. Th... |
| 09.11.2024 | The AI Transcription Showdown: Meeting.ai vs. Otter.ai | The landscape of AI transcription is evolving rapidly. As technology advances, competition heats up. Two players are at the forefront: Meeting.ai and Otter.ai. Both aim to capture the market, but their approaches differ significantly.
Speec... |
| 07.11.2024 | XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific | SINGAPORE, Nov. 7, 2024 /PRNewswire/ -- XtalPi (2228.HK) has announced a strategic partnership with Indonesia's powerhouse, led by one of its prominent business pillar Sinar Mas Multiartha. This landmark collaboration is set to transform th... |
| 10.10.2024 | Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform | CAMBRIDGE, Mass., Oct. 10, 2024 /PRNewswire/ -- XtalPi, a global leader in AI drug discovery, announced today a license agreement between Ailux Biologics, a division of XtalPi Inc., and Janssen Biotech, Inc.,(Janssen) a Johnson & Johnso... |
| 30.09.2024 | Tiny Black Holes: The Cosmic Ghosts That Could Shake Mars | In the vast expanse of our universe, mysteries lurk like shadows. Among them are tiny black holes, ancient remnants from the dawn of time. These elusive entities may drift through our Solar System, stirring the orbits of planets like Mars. ... |
| 24.09.2024 | XtalPi Launches Computational Chemistry Software for Drug Discovery: XMolGen and XFEP | BOSTON and SHANGHAI, Sept. 24, 2024 /PRNewswire/ -- Today, XtalPi announced the official launch of XFEP and XMolGen, two proprietary software products designed to accelerate and enhance the efficiency of drug discovery. Upon this launch, Xt... |
| 11.09.2024 | PhoreMost raises £33M to advance 'Drugging the Undruggable' research | PhoreMost, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, has completed an oversubscribed £33 million Series B investment round.
PhoreMost’s SITESEEKER platform can identify the best new the... |
| 21.08.2024 | 51World‘s earth cloning tech secures backing from Chinese state-owned investor | Header image source: 51World.
51World, a Beijing-based digital twin technology company, has raised RMB 200 million (USD 28 million) in a pre-IPO funding round, according to 36Kr. This latest investment marks a significant milestone for the ... |
| 11.03.2024 | Artificial Intelligence in Healthcare Market Size, Share And Growth Analysis For 2024-2033 | Artificial Intelligence In Healthcare Global Market Report 2024 – Market Size, Trends, And Global Forecast 2023-2032
The Business Research Company's Artificial Intelligence In Healthcare Global Market Report 2024 – Market Size, Trends, And ... |
| 30.01.2024 | XtalPi Unveils Ailux: A New Chapter in AI-Powered Biologics Discovery | CAMBRIDGE, Mass., Jan. 30, 2024 /PRNewswire/ -- XtalPi Inc. (XtalPi), a globally leading innovative R&D platform company that harnesses the power of artificial intelligence (AI), quantum physics-based computation, and robotic automation... |
| 27.11.2023 | XtalPi and HKU's Advanced Biomedical Instrumentation Centre Sign MoU to Accelerate Deep Tech Commercialization | CAMBRIDGE, Mass., Nov. 27, 2023 /PRNewswire/ -- XtalPi Inc. (XtalPi) and the Advanced Biomedical Instrumentation Centre (ABIC or the Centre) at the University of Hong Kong (HKU) have entered a memorandum of understanding (MoU) that outlines... |
| 31.05.2023 | XtalPi Announces Collaboration with Lilly, Using AI + Robotics to Uncover First-in-class Therapeutics | XtalPi Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, announced an AI drug discovery collaboration of up to $250 million in upfront and milestone payments with Eli Lilly and Comp... |
| 30.05.2023 | Sequoia China-Backed AI Startup Xtalpi To Partner With Pharma Giant Eli Lilly In $250 Million Novel Drug Deal | Ma Jian, cofounder and CEO of Xtalpi.Xtalpi |
| 20.12.2022 | XtalPi and EDDC collaborate in AI-empowered Drug Discovery program for Non-Small Cell Lung Cancer | XtalPi, a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, announced a strategic collaboration with the Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug ... |
| 25.11.2022 | XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development, opening a new paradigm for scientific innovation | AI-driven drug research and development (R&D) is breaking new ground, providing faster and more effective treatment options for more patients worldwide
SHENZHEN & HONG KONG, China, Nov. 24, 2022 /PRNewswire/ -- XtalPi announced toda... |
| 27.10.2022 | US sanctions on China could extend to biotech, official says | On the heels of the Biden administration’s decision to impose sweeping chip sanctions on China, there are signs that China might also lose access to other types of critical U.S. technologies including biotechnology, an area that has histori... |
| 19.01.2022 | XtalPi Partners with Excelra for GOSTAR to Enhance its Intelligent Digital Drug Discovery and Development platform | HYDERABAD, India and SHENZHEN, China, Jan. 19, 2022 /PRNewswire/ -- Excelra, a leading global Data & Analytics organization, today announced the partnership for its Global Online Structure Activity Relationship Database (GOSTAR) with Xt... |
| 04.10.2021 | 2021 is already a record breaking year for digital health funding | Funding to digital health companies surpassed $20 billion for the first time ever
COVID has taken digital health from a growing but still niche space to the mainstream. As fast as it was growing before the pandemic, it has now turned into a... |
| 16.08.2021 | XtalPi grabs $400M | Chinese drug discovery startup XtalPi has raised $400 million at a roughly $2 billion valuation, DealStreet Asia reported. OrbiMed and Hopu Investments co-led the Series D funding round. The startup partners with drugmakers including Pfizer... |
| 16.08.2021 | After attracting multiple Chinese pharma partners, XtalPi grabs another $400M to refine AI for drug discovery | Building the kind of artificial intelligence infrastructure required to make a dent in drug discovery takes real money — money that investors have been happy to lavish. Big players, or emerging ones flush with cash, are... |
| 12.08.2021 | AI pharma startup XtalPi nets USD 400 million in Series D round to accelerate drug discovery | AI pharmaceutical company XtalPi secured USD 400 million in a Series D financing round led by OrbiMed and RRJ, with investors including Sequoia Capital, Sino Biopharmecutical, and 5Y Capital participating in the deal. The new funds come les... |
| 11.08.2021 | XtalPi Inc. announced that it has received CNY 2.5918 billion in funding from OrbiMed Advisors LLC, RRJ Capital, Sequoia China Investment Management LLP, Sino Biopharmaceutical Limited, 5Y Capital, HO... | XtalPi Inc. announced it has received $400 million (CNY 2.5918 billion) in its series D round of funding led by OrbiMed Advisors LLC and RRJ Capital on August 11, 2021. The transaction also included participation from Sino Biopharmaceutical... |
| 30.06.2021 | COVID-19 как акселератор развития цифровой медицины: инвестиции, тренды, перспективы | COVID-19 как акселератор развития цифровой медицины: инвестиции, тренды, перспективы |
| 30.06.2021 | COVID-19 as an accelerator of digital healthcare development: investments, trends, perspectives | COVID-19 as an accelerator of digital healthcare development: investments, trends, perspectives |
| 07.10.2020 | Chinese drug startup Hinova raises 1 billion yuan to target prostate cancer and gout | |
| 29.09.2020 | AI-centered drug discovery startup XtalPi raises nearly $319M in Series C round | The company describes itself as having been founded in 2014 by quantum physicists at the Massachusetts Institute of Technology. In an email, spokesperson Ruyu Wang noted that since its founding, the company has added several biopharma indus... |
| 28.09.2020 | AI drug designer XtalPi raises $318M from SoftBank, Tencent, others for 'digital twin' simulation efforts | Artificial intelligence-based drug molecule designer XtalPi has secured a mammoth series C funding round totaling $318.8 million, raised from global investment companies across the banking and technology sectors.
Sponsored by Agilent Techno... |
| 28.09.2020 | AI Drug R&D Startup XtalPi Announces Over 300 Million Series C Investment Led by SoftBank Vision Fund, PICC Capital, and Morningside | |
| 28.09.2020 | Chinese pharmaceutical tech firm XtalPi nets $319m in Series C round | Premium
XtalPi Inc, a Chinese pharmaceutical firm that uses artificial intelligence (AI) to accelerate the development of new drugs, announced on Monday that it has garnered $318.8 million in a Series C round of financing.
Continue reading ... |
| 28.09.2020 | XtalPi lands massive $319M SoftBank-led round C to continue its high-tech drug discovery | XtalPi, an American-Chinese biotech firm that focuses on AI-assisted drug discovery, has raised a $319 million round C from a slate of enthusiastic investors led by SoftBank’s Vision Fund. It joins numerous others with 9-figure rounds in wh... |
| 18.06.2020 | Google parent company Alphabet is back in China (because it never left) | |
| 30.10.2018 | Term Sheet — Tuesday, October 30 | CRYPTO FUNDING
Good morning, Term Sheet readers.
Paid Content How can you protect what you can't see? From ExtraHop
The fresh infusion of capital will be used to accelerate global expansion and the offering of more cryptocurrencies.
A sourc... |
| 29.10.2018 | China Life leads $46m funding in Google-backed biotech startup XtalPi | Premium
China Life Healthcare Fund, the first flagship healthcare private equity fund of China Life, has led the $46-million funding round in XtalPi, a Google-backed biotech startup that integrates quantum physics and artificial intelligenc... |
| 29.10.2018 | Biotech startup XtalPi closes $46 million in Series B-1 extension to boost growth and accelerate platform development | Computation-driven biotech startup XtalPi continues to reinvent the pharmaceutical industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. We covered the 4-year old st... |
| 26.10.2018 | AI drug miner XtalPi raises another $46M in series B add-on
W h i t e p a p e r
Vital Precision for Cost Reduction, QA, and Regulatory Compliance | Chinese AI drug discovery startup XtalPi has raised another $46 million this year, in an extension of its venture capital round, to finance expansion of its computerized pharmaceutical research platform.
Sponsored by Agilent Technologies
Ho... |
| 24.10.2018 | XtalPi Announces The Closing Of $46 Million Series B-1 Extension | XtalPi Inc., a computation-driven biotech startup integrating quantum physics, artificial intelligence (AI), and cloud computing to empower pharmaceutical research, today announced a Series B-1 extension financing of $46 million to support ... |
| 24.10.2018 | XtalPi Closes $46M Series B-1 Extension Financing | XtalPi Inc., a Cambridge, Mass.-based computation-driven biotech startup integrating quantum physics, artificial intelligence (AI), and cloud computing to empower pharmaceutical research, raised $46m in Series B-1 extension financing.
The r... |
| 25.01.2018 | China AI biotech XtalPi lands $15M from Sequoia, Google, Tencent
W h i t e p a p e r
Vital Precision for Cost Reduction, QA, and Regulatory Compliance | As capital continues to pile onto applications of artificial intelligence in drug R&D, XtalPi, a Chinese startup working in that field, has secured a $15 million series B backed by high-profile tech investors Sequoia China, Google and C... |
| 24.01.2018 | China: Pharma startup XtalPi raises $15m led by Sequoia, joined by Google, Tencent | Premium
Alphabet Inc’s Google, Tencent Holdings Ltd and Sequoia Capital China have joined a $15 million B series funding round for Boston- and Shenzhen-based artificial intelligence (AI) pharmaceutical firm XtalPi Inc.
Continue reading this... |
| 24.01.2018 | AI Biotech XtalPi Closes $15M Series B Funding Round | XtalPi Inc., a Shenzen, China-based computation-driven pharmaceutical technology company, closed a $15m Series B funding round.
The round was led by Sequoia China, with participation from Google and existing investor Tencent. Existing inves... |
| 23.01.2018 | US-China biotech startup XtalPi lands $15M from Google, Tencent and Sequoia | Google continues to increase its presence in China after it joined Sequoia China and Tencent in a $15 million investment for XtalPi, a U.S.-China biotech firm that uses artificial intelligence and computing to accelerate the development of ... |
| - | XtalPi Invests in Novel Target Discovery Biotech PhoreMost in Oversubscribed Series B Financing | CAMBRIDGE, Mass., March 23, 2021 /PRNewswire/ -- XtalPi, an artificial intelligence (AI) drug discovery and development company, is pleased to announce its investment in the Series B financing of PhoreMost, a UK-based biopharmaceutical comp... |
| - | AI-centered drug discovery startup XtalPi raises nearly $319M in Series C round | A company founded by physicists and that is developing means to apply artificial intelligence to drug discovery and development has raised more than $300 million in a venture capital financing round.
Cambridge, Massachusetts-based XtalPi sa... |
